'EuroVacc 02' HIV vaccine trial begins in February 2005
...ger clinical trials." Development background The vaccine candidates for the trial - DNA-HIV-C and NYVAC-HIV...n Vaccine Effort against HIV/AIDS. NYVAC-HIV-C (a vaccine candidate based on poxvirus) was manufactured by sanofi pasteur - the vaccine division of Sanofi-Ave...NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
...folio of clinical research in HIV/AIDS prevention, vaccine and treatment research and development. This solicitation, the second of two Requests for Applications (RFAs), is designed to increase the efficiency, accountability and integration of NIAID's HIV/AIDS clinical research networks and enhance their cap...No increase in sexual risk taking among gay men in HIV-study
...y men participating in the world's first test of a vaccine to prevent HIV did not appear to become more risky sexually out of false hope that the vaccine being tested would protect them from infection. The study, authored by the B.C. Centre for Excellen...Flu vaccination benefits people of any age with high-risk medical conditions
...ecommended for influenza vaccination receive their vaccine from a general practitioner through a standardized...ur knowledge, this is the first study showing high vaccine effectiveness in reducing severe end points such as deaths (78 percent) and hospitalizations for acu...Flu vaccination impact on elderly deaths may be over-estimated
...er study, indicate that the shortage [of influenza vaccine in the 2004-2005 season] will have little impact [on mortality]," the authors conclude. "Other cohort studies suggest that the shortage will have a tremendous impact on mortality among the elderly. Either way, this vast disconnect between conclusions...HIV infection still on the rise
... write the authors. For instance, the search for a vaccine against HIV has so far produced only negative results, while microbicides have proved disappointing. Although the ABC message (abstinence, be faithful, use a condom) is popular with the American government, its application in other parts of the world...Risk factors affect parents' attitudes about STD vaccinations
...y of possible infection and the effectiveness of a vaccine weighed heavily in the decision-making process for...survey to test their reaction to nine hypothetical vaccine scenarios. Variables included the mode of transmission (sexually transmitted or not sexually transmi...Parents comfortable with vaccination for sexually transmitted infections for adolescent children
...ether the infection was curable, chronic or fatal; vaccine efficacy, 50, 70 or 90 percent effective; and whet...y, the severity of disease and the efficacy of the vaccine were much more salient dimensions to these parents than were sexual transmissibility.If these findin...Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
The varicella vaccine is almost 90 percent effective against chickenpox,...uch as the elderly. Since 1995, when the varicella vaccine was first introduced in the United States, it has greatly reduced the number of chickenpox cases and...Pathogen-mimicking vaccine as strategy for cancer therapy
...m the first clinical trial of a therapeutic cancer vaccine combining the synthetic bacterial DNA sequence, Cp...ially tricking the immune system into thinking the vaccine is a bacterial infection," says lead author Dr. Daniel Speiser from the LICR Lausanne Branch. "The i...Substance protects resilient staph bacteria
...coccus pathogens. "This could be very important to vaccine development because the PGA is present in every strain of the organism," Dr. Otto says. "If a vaccine can be developed to negate the effect of the PGA, it could be highly successful against all pathogen...HIV vaccine trial breaks ground for future research
The results of the world's first phase 3 HIV vaccine efficacy trial are reported in the March 1 issue o...tious Diseases, now available online. Although the vaccine was ineffective in preventing HIV infection, the trial represents a landmark in the fight against HI...$10-million study explores men's role in transmitting HPV
...in Brazil. The work could help determine whether a vaccine for males should be employed in the arsenal agains...ins. "We are only a year or two away from having a vaccine for women licensed by the U.S. Food and Drug Administration. We don't know if we need to vaccinate m...Lottery funding to aid research into superbugs
...nd develop more effective antimicrobial agents and vaccine strategies to treat lung infections. Professor Govan, who will work with colleagues at the Universities of Edinburgh, Liverpool, Belfast and Cardiff and the Health Protection Agency in London, said: "The prompt and appropriate use of antibiotics to c...Medical meeting to feature research findings and disease prevention and health promotion sessions
...ness care, and National policy issues related to vaccine supply and distribution. Topics to be discussed during the meeting will fall into five major areas: public health practice, clinical preventive medicine, healthcare quality improvement, prevention policy issues, and teaching preventive medicine. Th...First US kidney cancer vaccine trial underway at Columbia
The first U.S. kidney cancer vaccine trial is now underway at Columbia University Medic.... the cancer cells). About the Trial The Trovax vaccine with IL-2 trial is being conducted by a team of physicians, scientists, nurses, pharmacists, and soc...National Academies News: William H. Foege to receive Public Welfare Medal, Academy's highest honor
...s against the disease. When faced with a critical vaccine shortage, Foege and his colleagues made the difficult decision to vaccinate only those they determined to be at greatest risk of infection -- people in close contact with known victims. Later, as director of CDC's Smallpox Eradication Program, Foege ...Vaccinating school children and high risk groups is best strategy for slowing flu transmission
...y scientists at Emory University. The alternative vaccine plan is based on mathematical models developed by ...t of school children, ages 6 to 18, with influenza vaccine would reduce community-wide transmission to very low levels. School children are the population gro...NIAID begins enrolling volunteers for novel HIV vaccine study
A large clinical trial of a novel HIV vaccine has begun enrolling volunteers at sites in North A... Merck & Co. Inc. Merck developed the experimental vaccine to stimulate HIV-specific cellular immunity, which prompts the body to produce T cells that kill HIV...International efforts towards developing a vaccine against HIV infection have been given a much-neede...ies and organizations conducting or supporting HIV vaccine research. In June 2004, the G8 countries endorsed its goals, and will consider the new plan at its ...